LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Brain Stimulation has published two pivotal articles chronicling the ...

In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to emerge in late responders.

Research shows that vagus nerve stimulation can provide long-lasting benefits for patients who do not respond to conventional treatments Around 20% of adults in the United States will experience major ...

About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few treatment attempts, but up to one-third of patients have treatment-resistant ...

Nick Fournie was 24 years old when severe depression upended his life. Fournie had been married to his longtime sweetheart for two years, and had no reason to suspect he had any mental health issues. ...

Researchers report that vagus nerve stimulation helped many people with long-standing, treatment-resistant depression feel ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the preliminary results for the unipolar patient cohort of the RECOVER clinical study ...

The leadership group for the Texas Biomedical Device Center includes, from left, Dr. Michael Kilgard, Dr. Jane Wigginton, Dr. Seth Hays and Dr. Robert Rennaker. In a first-of-its-kind clinical study, ...

Sign up for CNN’s Stress, But Less newsletter. Our six-part mindfulness guide will inform and inspire you to reduce stress while learning how to harness it. Nick ...